Objectives: Enlargement and abnormal sulcation of the temporal lobes have been described as a hallmark of thanatophoric dysplasia, while less severe abnormalities of the temporal lobes can be seen in achondroplasia or hypochondroplasia. Compared to fetal neurosonography, fetal MRI offers various advantages in the assessment of brain malformations, and may be of value in the prenatal diagnosis of CNS abnormalities in various skeletal dysplasias. The aim of this study was to describe the spectrum of temporal lobe abnormalities in skeletal dysplasias in a perinatal setting, using fetal MRI as well as postnatal in vivo and postmortem brain MRI. Methods: We included 6 cases of thanatophoric dysplasia in which 1,5T or 3T fetal MRI had been performed between GW17 and 23. In 2 of those cases postmortem MRI at 3T and in 3 cases histological analysis with H&E-staining was available and enabled us to correlate postmortem findings with in utero fetal MRI results. In addition we included 1 fetal MRI and 3 postnatal MRI of fetuses with achondroplasia/hypochondroplasia. Results: Enlargement of the temporal lobes with abnormal sulcation was seen in all 6 subjects of thanatophoric dysplasia in fetal MRI and was confirmed in 2 cases with postmortem MRI and in 3 cases at autopsy. Abnormalities in the 4 subjects with achondroplasia/hypochondroplasia included bilateral or unilateral sagittalisation of the parahippocampal sulcus, seen both in fetal MRI as well as in postnatal MRI. Conclusions: Temporal lobe abnormalities of different severities can be an independent marker of the presence of a skeletal dysplasia, as seen both in thanatophoric dysplasia as well as achondroplasia/hypochondroplasia. With PI only, full agreement between prenatal and postmortem cerebral findings was achieved in 81.0% (68/84). Additional cerebral findings were detected in 4.8% (4/84). Some findings, mainly proliferation disorders, failed confirmation in 8.3% (7/84) and agreement was absent because of autolysis in 6.0% (5/84).
Objectives:
To evaluate the concordance of pathological investigation (PI) and virtual necropsy (VN) findings after termination of pregnancy (TOP) in fetuses with central nervous system (CNS) anomalies. Methods: All TOP's between 2006 and 2016 with prenatally detected CNS involvement and having a PI and/or VN were retrospectively analysed and concordance level was established. Results: Of 764 TOP's, 255 cases had a CNS anomaly detected prenatally (33.4%). Fetal chromosomal anomalies and cases without or with partial PI were excluded. We analysed 84, 7 and 68 cases with a PI, a VN or both postmortem investigations respectively.
With PI only, full agreement between prenatal and postmortem cerebral findings was achieved in 81.0% (68/84). Additional cerebral findings were detected in 4.8% (4/84). Some findings, mainly proliferation disorders, failed confirmation in 8.3% (7/84) and agreement was absent because of autolysis in 6.0% (5/84).
Full cerebral agreement was present in all 7 cases when using a VN only as post-TOP investigation method.
A combination of VN and PI resulted in a full concordance of cerebral findings in 79.4% (54/68). In 54 cases, VN was able to confirm the prenatal diagnosis. However, classical brain PI revealed insufficient information because of autolysis in 12/54 cases (22.2%). Additional cerebral findings were present in 11 cases, of which in 3 cases histology was superior to VN in the detection of additional lesions. Additional extracerebral findings were present in 14 cases, in which gross pathological investigation was superior to VN in 3 cases. In 2 cases with no postmortem agreement, findings in PI and VN were concordant. Conclusions: Prenatally detected cerebral anomalies could always be confirmed by a VN. PI was insufficient to provide confirmation in 15.8% (24/152). Additional findings, important in etiological work-up and counselling, can be detected with a combination of VN, gross pathological investigation and directed histological analysis. Objectives: Women affected by PE/IUGR are noted to have a higher risk of cardiovascular (CV) disease later in life. It is hypothesised that subtle perturbations in maternal CV function might be present prior to conception, which pre-disposes women to PE/IUGR due to increasing physiological strain of pregnancy, and CV disease late in life due to age related changes. To investigate this, we conducted a prospective pre-conception study of healthy women planning a pregnancy, to examine the relationship between pre-conception CV parameters and conception of a pregnancy complicated by PE /IUGR. Methods: 527 healthy women (BMI < 35, non-smokers with no cardiovascular co-morbidities) planning to conceive naturally were recruited. All had non-invasive measurements of cardiac output (CO), peripheral and central blood pressure (BP), systemic vascular resistance (PVR), arterial stiffness and exercise testing prior to pregnancy and once pregnant, longitudinal repeat measurements every trimester until postpartum. Results: 218 women conceived a pregnancy which resulted in a live birth within study timeline, of which 14 had a pregnancy affected by PE or IUGR. Interval between pre-conception CV measurements and conception was 3.9 months. Adjusting for BMI, parity and age, women who developed PE/IUGR had significantly lower pre-conception CO (5.8 ± 1.0 vs. 5.0 ± 0.6 L/min; p = 0.007), and higher PVR (Mann-Whitney mean rank 105 vs. 167; p <0.001) and BP (p =0.026) compared to those with healthy pregnancy. Stress exercise testing revealed significantly different responses in terms of increments in stroke volume (p=0.02) and heart rate (p=0.04) between groups. Conclusions: In healthy women, significantly different central hemodynamic patterns and stress responses prior to conception, are associated with subsequent development of PE/IUGR. This raises
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